Gilead Focuses On Researching HIV, Hepatitis B Treatments After Success Finding HCV Cure

Bloomberg Business: After Curing Hepatitis C, Gilead Works to Vanquish More Viruses
“Gilead Sciences Inc., basking in the success of its cure for hepatitis C, is setting ambitious goals to vanquish two other major viral scourges: HIV and hepatitis B. Even with some promising signs in early trials, the biggest biotechnology firm in the world faces long odds in finding a way to rid humanity of the diseases…” (Chen, 8/17).